What is CoolStat?
CoolStat, developed by CoolTech Medical, specializes in pioneering temperature management solutions. Their flagship product, CoolStat, employs advanced evaporative cooling technology to offer patients a comfortable, portable, and user-friendly method for temperature regulation in clinical environments. Currently undergoing investigational use, the CoolStat device is being explored for applications in managing conditions such as neurogenic fever and post-cardiac arrest care, aiming to provide a safer, non-invasive alternative to existing hospital cooling systems.
How much funding has CoolStat raised?
CoolStat has raised a total of $200K across 1 funding round:
Angel/Seed
$200K
Angel/Seed (2022): $200K with participation from Tedco
Key Investors in CoolStat
Tedco
TEDCO, the Maryland Technology Development Corporation, is an organization focused on fostering an inclusive entrepreneurial innovation ecosystem. They identify, invest in, and support the growth of technology and life science-based companies within Maryland.
What's next for CoolStat?
With the recent influx of capital from a major strategic investment, CoolStat is poised to accelerate its development and commercialization efforts. This large-scale late-stage funding will likely be directed towards expanding clinical trials, securing regulatory approvals, and scaling manufacturing capabilities. The company's focus on innovative, non-invasive patient temperature management suggests a strategic push to capture market share in critical care and temperature-sensitive medical applications, potentially leading to broader adoption across healthcare systems.
See full CoolStat company page
